SHL Medical participates in 2022 PDA
SHL Medical is excited to announce its return in-person to the 2022 Parenteral Drug Association’s (PDA) annual Universe of Pre-filled Syringes and Injection Devices. The two-day event will be held on October 18-19 at Palm Springs, USA. SHL representatives will be present on-site at Booth #400 to interact with visitors and answer any inquiries related to its offerings.
One of the device solutions that will be featured in SHL’s booth this year is Maggie® autoinjectors. Built with our market-proven Needle Isolation Technology (NIT®), Maggie autoinjectors were developed to accommodate up to 3.0 mL injection volume. Fresh this year is the introduction of Maggie 5.0 – developed to facilitate injection volume traditionally only possible in on-body solutions.
Accompanying Maggie is our Molly® modular platform technology autoinjectors. Following the launch of Molly webpage and Molly white paper, this October, SHL teases an update in the Molly technology, focusing on enhancing patients’ injection experience via new customization options.
Visitors of our booth can also take a closer look at InsulCheck® DOSE – a connected device add-on for pen injectors, developed in collaboration with our partner, Innovation Zed and learn more about SHL’s digital healthcare. As the third-generation product from the InsulCheck family, DOSE is an integral part of SHL’s digital health ecosystem. Fully aware that connected healthcare is evolving fast and has great potential to answer unmet patient needs, SHL’s digital health initiative introduces the innovation partnership program. The co-development model allows pharmas to combine SHL’s technological capabilities and their clinical innovations to enable legacy autoinjectors to mature into the digital space with connected features, interoperable capabilities, and supportive digital ecosystem.
This year, SHL will also speak for PDA’s podium and poster presentations. For full list of our speakers and presentation topics, please refer to the table below.
Podium presentations
| Presentation Title | Speakers | Time |
| Addressing primary container challenges in autoinjector drug delivery: Interim results of a multiphase bioburden study for a cartridge-based autoinjector |
Lauren Guimond, MSE, Manager of Analytical Sciences at SHL Medical |
October 18th 13:50 pm PDT | Track B1 |
| Digital healthcare in drug delivery: The pillars of hardware and software to empower the end user |
Dean Minnock, PhD, CEO at Innovation Zed |
October 18th 15:45 pm PDT | Track A2 |
| Optimization of design transfer and commercial scale-up: An autoinjector case study |
Seungyil Yoon, PhD, Vice President of Drug Product Development at Samsung Bioepis
Amy Hartl, PhD, Director of Process Development at SHL Medical |
October 19th 11:05 am PDT | Track A3 |
Poster presentation
| Poster Title | Authors |
| An iterative process utilizing real world data collection to improve support for patients with diabetes |
Chelsea Williams, MPH, Digital Health Manager at SHL Medical
Jesus Sanchez, MSc, Assistant Manager of Emerging Tech. Development at SHL Medical
Gene Rhode F. Pantig, RPh, Senior Scientific Comm. Specialist at SHL Medical
William Cirillo, CTO at Innovation Zed |
We welcome participants to visit our booth and set up a meeting with our team members to learn more about SHL’s technologies and solutions.
Where : Palm Springs Convention Center, Palm Springs, CA, USA | Booth #400
When : October 18-19
